Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Smoothened (Smo) Inhibitor Lde225 Combined With Nilotinib In Patients With Chronic Myeloid Leukemia (Cml) Resistant/Intolerant (R/I) To At Least 1 Prior Tyrosine Kinase Inhibitor: A Phase 1B Study

Ottmann, Oliver, Charbonnier, A., Stegelmann, F., Breccia, M., Steegmann, J. L., Olavarria, E., Jevtic, S., Cota, M., Scheuer, N. and Lipton, J. H. 2015. Smoothened (Smo) Inhibitor Lde225 Combined With Nilotinib In Patients With Chronic Myeloid Leukemia (Cml) Resistant/Intolerant (R/I) To At Least 1 Prior Tyrosine Kinase Inhibitor: A Phase 1B Study. Haematologica 100 , pp. 62-63.

Full text not available from this repository.
Item Type: Article
Status: Published
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
Publisher: Ferrata Storti Foundation
ISSN: 0390-6078
Last Modified: 04 Jun 2017 09:33
URI: http://orca.cf.ac.uk/id/eprint/96771

Actions (repository staff only)

Edit Item Edit Item